<DOC>
	<DOCNO>NCT02703324</DOCNO>
	<brief_summary>This study evaluate blood sugar lower insulin , LY900014 , deliver insulin pump continuously skin . The study conduct participant type 1 diabetes mellitus investigate human body process LY900014 effect blood sugar level deliver via insulin pump . Side effect tolerability document .</brief_summary>
	<brief_title>A Study LY900014 Formulation Participants With Type 1 Diabetes Mellitus Using Insulin Pumps</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Male female participant Type 1 Diabetes Mellitus ( T1DM ) receive insulin therapy via approved insulin pump Have body mass index ( BMI ) 18.5 33 kilogram per square meter ( kg/mÂ² ) , inclusive , screen Have blood pressure , pulse rate , electrocardiogram ( ECG ) , blood urine laboratory test result acceptable study Have episode severe hypoglycemia past 6 month ( require assistance treatment second party ) Have venous access sufficient allow blood sample Have provide write consent willing follow study procedure commit study duration Are currently participate complete clinical trial within last 30 day clinical trial type medical research judge incompatible study Have previously participate withdrawn study Have use health problem , laboratory test result , blood pressure ECG reading , opinion doctor , could make unsafe participate study Had blood loss 500 milliliter ( mL ) within last month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>